The Nex Playground is on track to move 600,000 consoles, quadrupling last year’s sales. The Nex Playground is on track to move 600,000 consoles, quadrupling last year’s sales. is the Verge’s weekend ...
Posts from this topic will be added to your daily email digest and your homepage feed. We also found great deals on a retro-futuristic power strip and Hoto’s handy PixelDrive electric screwdriver. We ...
SINGAPORE – Isetan Serangoon Central at NEX Mall will close its doors in April 2026, a move which will leave the department store with one outlet in Singapore. In a Facebook post on Dec 8, NEX ...
TL;DR: During Black Friday 2025 in the U.S., the NEX Playground, a compact, affordable Android-based console with motion-sensing features, outsold the Xbox Series X|S. The PlayStation 5 led sales with ...
The affordability crisis has the industry caught in a pincer grip. With hardware priced too high to allow for healthy audience growth, even as software is often priced too low for many games to make a ...
Aaron McKinley is a writer, blogger and video game enthusiast with over five years of experience in web content and many more in playing games until the wee hours of the morning. His work spans many ...
Intel Corp. has scrapped plans to sell its multibillion-dollar NEX networking chip business. The company announced the move on Wednesday in a statement issued to Tom’s Hardware. The reversal comes ...
We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Haley Perry Haley Perry is ...
Intellia Therapeutics ( (NTLA)) has provided an update. On November 8, 2025, Intellia Therapeutics announced positive results from its Phase 1/2 trial of lonvoguran ziclumeran (lonvo-z) for hereditary ...
One-time treatment of nex-z led to consistently rapid, deep and durable reduction in serum TTR through three years of follow-up Consistent trend in disease stability or improvement in multiple ...
The patient who was hospitalized after receiving Intellia Therapeutics’ CRISPR therapy nex-z has died. Both phase 3 studies of the candidate remain on hold as the biotech works to understand ...
At least five Wall Street firms have downgraded their ratings on Intellia Therapeutics (NASDAQ:NTLA) in the wake of the company's announcement it was pausing enrollment in two phase three trials of ...